These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 7248483)
1. Estimation of the systemic bioavailability of timolol in man. El-Rashidy R Biopharm Drug Dispos; 1981; 2(2):197-202. PubMed ID: 7248483 [TBL] [Abstract][Full Text] [Related]
2. Timolol and propranolol: bioavailability, plasma concentrations, and beta blockade. Wilson TW; Firor WB; Johnson GE; Holmes GI; Tsianco MC; Huber PB; Davies RO Clin Pharmacol Ther; 1982 Dec; 32(6):676-85. PubMed ID: 7140133 [TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacologic observations on timolol. I. Disposition and effect in relation to plasma level in normal individuals. Ishizaki T; Tawara K; Oyama Y; Nakaya H J Clin Pharmacol; 1978; 18(11-12):511-8. PubMed ID: 721948 [TBL] [Abstract][Full Text] [Related]
4. Comparison of disposition and effect of timolol and propranolol on exercise tachycardia. Ishizaki T; Tawara K Eur J Clin Pharmacol; 1978 Nov; 14(1):7-14. PubMed ID: 32043 [TBL] [Abstract][Full Text] [Related]
6. Comparisons of the interaction of propranolol and timolol with model and biological membrane systems. Herbette L; Katz AM; Sturtevant JM Mol Pharmacol; 1983 Sep; 24(2):259-69. PubMed ID: 6888369 [TBL] [Abstract][Full Text] [Related]
7. Uptake of the beta-adrenergic blocking agents propranolol and timolol by rodent brain: relationship to central pharmacological actions. Tocco DJ; Clineschmidt BV; Duncan AE; deLuna FA; Baer JE J Cardiovasc Pharmacol; 1980; 2(2):133-43. PubMed ID: 6171681 [No Abstract] [Full Text] [Related]
9. The disposition of timolol in man. Vermeij P; el-Sherbini-Schepers M; van Zwieten PA J Pharm Pharmacol; 1978 Jan; 30(1):53-5. PubMed ID: 22728 [No Abstract] [Full Text] [Related]
10. Pharmacokinetic differences between single and multiple oral dosing with the guidance for beta-adrenoceptor blockade assessment. Ishizaki T; Tawara K Cardiology; 1979; 64 Suppl 1():25-43. PubMed ID: 42487 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic interactions of timolol with vasodilating drugs, food and phenobarbitone in healthy human volunteers. Mäntylä R; Männistö P; Nykänen S; Koponen A; Lamminsivu U Eur J Clin Pharmacol; 1983; 24(2):227-30. PubMed ID: 6840172 [TBL] [Abstract][Full Text] [Related]
12. Stereospecific binding of timolol, a beta-adrenergic blocking agent. Tocco DJ; Hooke KF; Deluna FA; Duncan AE Drug Metab Dispos; 1976; 4(4):323-9. PubMed ID: 8286 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of intravenous timolol in patients with acute myocardial infarction and in healthy volunteers. Vedin JA; Kristianson JK; Wilhelmsson CE Eur J Clin Pharmacol; 1982; 23(1):43-7. PubMed ID: 7128671 [TBL] [Abstract][Full Text] [Related]
14. Active transport of beta-adrenergic blocking agents in the anterior uvea of albino rabbit. Matsumoto S; Araie M; Takase M Jpn J Ophthalmol; 1986; 30(4):339-50. PubMed ID: 2884338 [TBL] [Abstract][Full Text] [Related]
15. Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops. Korte JM; Kaila T; Saari KM Graefes Arch Clin Exp Ophthalmol; 2002 Jun; 240(6):430-5. PubMed ID: 12107508 [TBL] [Abstract][Full Text] [Related]
19. Plasma timolol levels after oral and intravenous administration. Else OF; Sorenson H; Edwards IR Eur J Clin Pharmacol; 1978 Dec; 14(6):431-4. PubMed ID: 738350 [TBL] [Abstract][Full Text] [Related]
20. Absolute bioavailability study in the dog with Visacor, a new cardioselective beta blocking drug with intrinsic sympathomimetic activity. McAinsh J; Smith RP; Ferguson RA Eur J Drug Metab Pharmacokinet; 1984; 9(2):129-39. PubMed ID: 6146530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]